Mass Spectrometry Market Projected to Surpass USD 11.25

From GlobeNewswire: 2024-11-19 09:00:00

The Mass Spectrometry Market is projected to reach USD 11.25 billion by 2032, growing at a CAGR of 7.74%. This growth is driven by increased applications in pharmaceuticals, healthcare, and food safety. Advancements in instrument sensitivity and automation, alongside a focus on R&D activities, contribute to market expansion.

Mass spectrometry plays a crucial role in proteomics, metabolomics, clinical diagnostics, and environmental analysis. Its ability to identify and quantify compounds accurately is essential for industries requiring precise molecular data. The demand for mass spectrometers is rising in pharmaceutical research, environmental testing, and food safety, leading to market growth.

Hybrid mass spectrometry instruments dominated the market in 2023, contributing to 48.0% of total revenue. Software & services are the fastest-growing segment, driven by data-intensive techniques like high-throughput screening. LC-MS is the largest sample preparation technique, while ICP-MS is rapidly growing due to its precision in detecting trace elements and isotopes.

North America leads the mass spectrometry market, driven by pharmaceutical, biotechnology, and environmental sectors. The Asia-Pacific region is the fastest-growing market, fueled by industrialization and advancements in research. APAC countries like China, Japan, and India are emerging as key players in the market, with a focus on healthcare and environmental monitoring.

In November 2024, researchers at the University of Massachusetts developed a method for detecting PFAS in water using advanced mass spectrometry techniques. This innovation highlights the continuous advancements and applications of mass spectrometry in various industries. In August 2024, Caltech introduced a new fingerprint mass spectrometry method to enhance proteomics, leading to improved diagnostics and treatments for various diseases. In July 2024, Thermo Fisher Scientific launched the Orbitrap Exploris 240, offering enhanced resolution and sensitivity for drug discovery, clinical diagnostics, and proteomics. The mass spectrometry market is rapidly evolving to meet regulatory requirements and growing demand, with continued growth expected across industries like pharmaceuticals and environmental testing. Discover more insights with SNS Insider’s Mass Spectrometry Market Analysis & Outlook Report 2024-2032.



Read more at GlobeNewswire: Mass Spectrometry Market Projected to Surpass USD 11.25